Humira Sales Data
| Rank 3 | Current sales rank, all U.S. Pharmaceuticals. |
Last updated: February 2014 (updated quarterly).
The following data shows Humira U.S. retail sales in Q4 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q4 2013 | 3 | $1,461,861 | 3.86% | 669 | 1.52% |
| Q3 2013 | 3 | $1,407,506 | 4.90% | 659 | -4.91% |
| Q2 2013 | 3 ( 3) |
$1,341,759 | 10.22% | 693 | 9.83% |
| Q1 2013 | 6 ( 1) |
$1,217,353 | 0.91% | 631 | -5.68% |
| Q4 2012 | 5 | $1,206,377 | 4.70% | 669 | 4.53% |
| Q3 2012 | 5 (2) |
$1,152,261 | 13.45% | 640 | 7.56% |
| Q2 2012 | 7 (3) |
$1,015,639 | 9.43% | 595 | 8.97% |
| Q1 2012 | 10 | $928,124 | 2.50% | 546 | -2.85% |
| Q4 2011 | 10 (1) |
$905,527 | 3.18% | 562 | 2.55% |
| Q3 2011 | 11 (3) |
$877,641 | 3.95% | 548 | 3.01% |
| Q2 2011 | 14 | $844,296 | 6.32% | 532 | 2.31% |
| Q1 2011 | 14 | $794,076 | n/a | 520 | n/a |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
